SLED in CKD: Not a Standard Therapy
Sustained low-efficiency dialysis (SLED) is not indicated for chronic kidney disease (CKD) management—it is specifically designed for acute kidney injury (AKI) in critically ill patients, not for chronic end-stage kidney disease requiring maintenance dialysis.
Critical Distinction: SLED vs. Standard Hemodialysis
SLED represents a hybrid renal replacement therapy modality that bridges intermittent hemodialysis and continuous renal replacement therapy (CRRT). The evidence base exclusively addresses its use in intensive care unit settings for AKI, not for outpatient CKD management 1, 2, 3.
When SLED is Actually Used
SLED is employed in the following specific clinical scenarios:
- Critically ill patients with AKI who are hemodynamically unstable and cannot tolerate conventional intermittent hemodialysis 3
- Alternative to CRRT when continuous therapy equipment is unavailable or cost-prohibitive 4
- ICU patients requiring prolonged dialysis with better hemodynamic tolerance than standard hemodialysis 1
Technical Specifications for SLED (When Used in AKI)
Prescription Parameters
- Duration: 8-12 hours per session, typically performed nocturnally 4, 3
- Frequency: 6 days per week or daily 4
- Blood flow rate: 200 mL/min (lower than conventional HD) 4
- Dialysate flow rate: 300-350 mL/min (significantly reduced compared to standard HD) 4
- Hemofiltration: Can add 1 L saline/hour 4
Anticoagulation Options
- Heparin-free protocols: Successfully used in 65% of treatments 4
- Regional citrate anticoagulation: Increasingly utilized with target circuit citrate concentration of 2.5-3 mmol/L 5
- Standard heparin: When anticoagulation is necessary and not contraindicated 4
Common pitfall: Filter clotting occurs in 18-29% of treatments regardless of anticoagulation strategy 4, requiring close monitoring.
Efficacy Metrics
SLED achieves comparable solute clearance to CRRT:
- Weekly Kt/V: 8.4 ± 1.8 4
- Equivalent renal clearance: 29 ± 6 mL/min 4
- Mean delivered double-pool Kt/V: 1.36 per completed treatment 3
- Phosphate removal: 1.5 g per treatment 3
Monitoring Requirements
During Treatment
- Continuous hemodynamic monitoring (blood pressure, heart rate)
- Circuit pressures and blood flow rates
- Ultrafiltration goals and achievement 3
Laboratory Monitoring
When using citrate anticoagulation, extensive monitoring is required 5:
- Serum citrate levels (direct measurement by enzymatic methods)
- Ionized calcium (calcium infusion needed in 23% of sessions) 5
- Phosphate and magnesium (supplementation required in ~25% of sessions) 5
- Electrolyte panel (risk of hypokalemia and hypophosphatemia) 3
What CKD Patients Actually Need
For patients with chronic kidney disease requiring maintenance dialysis, the KDIGO 2015 guidelines specify 6:
Standard Hemodialysis Prescription
- Target spKt/V: 1.4 per session for thrice-weekly treatment
- Minimum delivered spKt/V: 1.2 6
- Minimum treatment time: 3 hours per session for patients with residual kidney function <2 mL/min 6
- Standard Kt/V: 2.3 volumes per week for non-thrice-weekly schedules 6
Membrane Selection
Use biocompatible (synthetic) high or low flux membranes for intermittent hemodialysis 6—the same principle applies to SLED when used for AKI 7.
Cost Considerations
SLED demonstrates significant cost advantages over CRRT in the ICU setting 4:
- SLED: $1,431 per week
- CRRT with heparin: $2,607 per week
- CRRT with citrate: $3,089 per week
This cost-effectiveness makes SLED particularly valuable in resource-limited settings 2, but this comparison is irrelevant for outpatient CKD management.
Clinical Outcomes
In critically ill patients with AKI, SLED achieves:
- Hemodynamic stability during most treatments 3
- Prescribed ultrafiltration goals with mean shortfall of only 240 mL per treatment 3
- Hospital mortality: 62.2%, not significantly different from APACHE II-predicted mortality 3
- Similar patient survival and renal recovery compared to CRRT 2
Key caveat: These outcomes apply only to the acute setting, not chronic dialysis patients.
Bottom Line
If you are asking about SLED for a patient with chronic kidney disease requiring maintenance dialysis, the answer is to use standard intermittent hemodialysis following KDIGO adequacy guidelines 6. SLED is reserved exclusively for hemodynamically unstable ICU patients with acute kidney injury who cannot tolerate conventional hemodialysis or when CRRT is unavailable 1, 2, 3.